Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Revenue: 2014-2025

Historic Revenue for vTv Therapeutics (VTVT) over the last 10 years, with Sep 2025 value amounting to -$5,000.

  • vTv Therapeutics' Revenue was N/A to -$5,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is 1068.97% up from last year.
  • vTv Therapeutics' Revenue amounted to -$5,000 in Q3 2025, which was down 129.41% from $17,000 recorded in Q4 2024.
  • In the past 5 years, vTv Therapeutics' Revenue registered a high of $3.0 million during Q3 2021, and its lowest value of -$7,000 during Q4 2023.
  • Its 3-year average for Revenue is $157,000, with a median of -$2,000 in 2023.
  • In the last 5 years, vTv Therapeutics' Revenue skyrocketed by 42,757.14% in 2021 and then tumbled by 177.78% in 2023.
  • Over the past 5 years, vTv Therapeutics' Revenue (Quarterly) stood at $9,000 in 2021, then remained steady at $9,000 in 2022, then plummeted by 177.78% to -$7,000 in 2023, then soared by 342.86% to $17,000 in 2024, then reached -$5,000 in 2025.
  • Its Revenue was -$5,000 in Q3 2025, compared to $17,000 in Q4 2024 and $1.0 million in Q1 2024.